Mirae Asset Global ETFs Holdings’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$447K Buy
29,812
+2,794
+10% +$41.9K ﹤0.01% 1875
2025
Q1
$442K Buy
27,018
+4,277
+19% +$69.9K ﹤0.01% 1939
2024
Q4
$527K Buy
22,741
+916
+4% +$21.2K ﹤0.01% 1893
2024
Q3
$639K Buy
21,825
+19,299
+764% +$565K ﹤0.01% 1793
2024
Q2
$57.4K Buy
+2,526
New +$57.4K ﹤0.01% 2754